Intellinetics, Inc. (INLX) Dividend History

Intellinetics, Inc. (INLX) is a provider of document management and enterprise content management solutions. The company specializes in developing software that helps organizations digitize, organize, and automate their document workflows to improve efficiency and compliance. It offers cloud-based and on-premise platforms tailored to various industries, including healthcare, government, and commercial sectors.

Dividend History

Intellinetics, Inc. currently does not pay dividends

Company News

  • Cutera (CUTR) delivered earnings and revenue surprises of 6.42% and 4.38%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?

    Zacks Investment Research
  • COLUMBUS, OH, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Intellinetics, Inc. (NYSE American: INLX), a digital transformation solutions provider, today announced that management will participate in the Winter Wonderland Best Ideas Virtual Investor Conference which will be held virtually on February 21-24, 2023. James F. DeSocio, President & CEO, and Joe Spain, CFO are scheduled to host a virtual presentation on Wednesday, February 22 at 10 a.m. ET, followed by a Q&A session. Management will also host one-on-one meetings with investors on February 23-24, 2023. All existing and prospective shareholders are invited to listen to the webcast to learn more about the Company.

    GlobeNewswire Inc.
  • Gainers FOXO Technologies Inc. (NYSE: FOXO) rose 161% to $10.50 in pre-market trading after dipping 52% on Friday. Amprius Technologies, Inc. (NYSE: AMPX) shares rose 20.5% to $10.00 in pre-market trading after declining 17% on Friday. bluebird bio, Inc. (NASDAQ: BLUE) rose 18.5% to $7.52 in pre-market trading. bluebird bio disclosed that the Food and Drug Administration approved its gene therapy for a rare neurodegenerative disease. NexImmune, Inc. (NASDAQ: NEXI) rose 15.6% to $0.76 in pre-market trading. NexImmune and Selexis recently signed a service agreement to develop cell lines targeting rare cancers and autoimmune diseases. Secoo Holding Limited (NASDAQ: SECO) rose 14% to $0.3999 in pre-market trading. Aladdin Technology Group recently agreed to invest RMB1.3 million in the company. VEON Ltd. (NASDAQ: VEON) rose 13.8% to $0.41 in pre-market trading after dropping 18% on Friday. VEON Group’s consolidated revenue rose 3.1% year-on-year for the first eight months of 2022. Senti Biosciences, Inc. (NASDAQ: SNTI) rose 13.7% to $1.82 in pre-market trading after dipping around 29% on Friday. Golden Minerals Company (NYSE: AUMN) rose 11.4% to $0.2562 in pre-market trading after dropping 10% on Friday. Kalera Public Limited Company (NASDAQ: KAL) rose 11.1% to $1.50 in pre-market trading after declining 27% on Friday. Kalera posted Q2 adjusted loss of $1.20 per share. Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ: SHPH) rose 10.2% to $9.91 ...

    Benzinga
Page data last updated 07/24/2025 23:11:04 UTC